AngioDynamics (ANGO) Q4 2026 Earnings Report

533 Followers

ANGO Q4 2026 EPS Results

Actual EPS-$0.07

Consensus EPS-$0.09

Beat/MissBeat by +$0.02

One Year Ago EPS-$0.03

Actual Revenue$86.61M

Expected Revenue$80.24M

Beat/MissBeat by +$6.37M

YoY Revenue Growth+8.05%

QuarterQ4 2026

Date07/14/2026

TimeBefore Open

Conference CallTuesday, July 14, 2026

ANGO Upcoming Earnings

AngioDynamics's next earnings date is estimated for January 7, 2027, based on past reporting schedules.

ANGO Q4 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Jan 07, 2027	2027 (Q2)	-0.07 / -	0	―
Oct 08, 2026	2027 (Q1)	-0.11 / -0.04	-0.1	60.00% (+0.06)
Jul 14, 2026	2026 (Q4)	-0.09 / -0.07	-0.03	-133.33% (-0.04)
Apr 02, 2026	2026 (Q3)	-0.11 / 0.02	-0.08	125.00% (+0.10)
Jan 06, 2026	2026 (Q2)	-0.10 / 0.00	-0.04	―
Oct 02, 2025	2026 (Q1)	-0.12 / -0.10	-0.11	9.09% (<+0.01)
Jul 15, 2025	2025 (Q4)	-0.12 / -0.03	-0.06	50.00% (+0.03)
Apr 02, 2025	2025 (Q3)	-0.13 / -0.08	-0.16	50.00% (+0.08)
Jan 08, 2025	2025 (Q2)	-0.11 / -0.04	-0.05	20.00% (+0.01)
Oct 03, 2024	2025 (Q1)	-0.15 / -0.11	-0.12	8.33% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed